HK1188442A1 - 氮雜 中氮茚衍生物及其藥物用途 - Google Patents

氮雜 中氮茚衍生物及其藥物用途

Info

Publication number
HK1188442A1
HK1188442A1 HK14100528.5A HK14100528A HK1188442A1 HK 1188442 A1 HK1188442 A1 HK 1188442A1 HK 14100528 A HK14100528 A HK 14100528A HK 1188442 A1 HK1188442 A1 HK 1188442A1
Authority
HK
Hong Kong
Prior art keywords
aza
pharmaceutical use
indolizine derivative
indolizine
derivative
Prior art date
Application number
HK14100528.5A
Other languages
English (en)
Inventor
Masato Iizuka
Kazuo Shimizu
Original Assignee
橘生藥品工業株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 橘生藥品工業株式會社 filed Critical 橘生藥品工業株式會社
Publication of HK1188442A1 publication Critical patent/HK1188442A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14100528.5A 2010-09-29 2014-01-17 氮雜 中氮茚衍生物及其藥物用途 HK1188442A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010219600 2010-09-29
PCT/JP2011/072201 WO2012043638A1 (ja) 2010-09-29 2011-09-28 （アザ）インドリジン誘導体及びその医薬用途

Publications (1)

Publication Number Publication Date
HK1188442A1 true HK1188442A1 (zh) 2014-05-02

Family

ID=45893077

Family Applications (2)

Application Number Title Priority Date Filing Date
HK14100528.5A HK1188442A1 (zh) 2010-09-29 2014-01-17 氮雜 中氮茚衍生物及其藥物用途
HK15107096.1A HK1206360A1 (zh) 2010-09-29 2015-07-24 氮雜 中氮茚衍生物及其藥物用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15107096.1A HK1206360A1 (zh) 2010-09-29 2015-07-24 氮雜 中氮茚衍生物及其藥物用途

Country Status (9)

Country Link
US (1) US9643969B2 (zh)
EP (1) EP2623505B1 (zh)
JP (1) JP5906191B2 (zh)
KR (1) KR20130099064A (zh)
CN (2) CN103221412B (zh)
CA (1) CA2811773A1 (zh)
ES (1) ES2549926T3 (zh)
HK (2) HK1188442A1 (zh)
WO (1) WO2012043638A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014143607A1 (en) 2013-03-11 2014-09-18 Bristol-Myers Squibb Company Pyrrolopyridazines as potassium ion channel inhibitors
WO2014143606A1 (en) 2013-03-11 2014-09-18 Bristol-Myers Squibb Company Pyrrolotriazines as potassium ion channel inhibitors
SG10201806849WA (en) 2014-02-13 2018-09-27 Incyte Corp Cyclopropylamines as lsd1 inhibitors
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
ME03580B (me) 2014-02-13 2020-07-20 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
EP3392244A1 (en) 2014-02-13 2018-10-24 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
WO2016007727A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
CN107660205B (zh) 2015-04-03 2021-08-27 因赛特公司 作为lsd1抑制剂的杂环化合物
CR20180152A (es) 2015-08-12 2018-08-09 Incyte Corp Sales de un inhibidor de lsd1
EP3344604B1 (en) * 2015-09-02 2020-11-04 Sunshine Lake Pharma Co., Ltd. Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
CA3018115A1 (en) * 2015-12-28 2017-07-06 Shanghai Fochon Pharmaceutical Co., Ltd. Indolizine derivatives, composition and methods of use
TWI828027B (zh) 2016-03-28 2024-01-01 美商英塞特公司 作為tam抑制劑之吡咯并三嗪化合物
CA3021678A1 (en) 2016-04-22 2017-10-26 Incyte Corporation Formulations of an lsd1 inhibitor
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
CN111943957B (zh) * 2019-05-17 2023-01-06 中国医学科学院药物研究所 喹啉甲酰胺类化合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193926A (en) * 1979-07-06 1984-05-31 Labaz Sanofi Nv 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines
JP5222561B2 (ja) * 2005-10-07 2013-06-26 キッセイ薬品工業株式会社 含窒素芳香族複素環化合物およびそれを含有する医薬組成物
WO2007056170A2 (en) * 2005-11-02 2007-05-18 Bayer Healthcare Ag Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
JP5330990B2 (ja) 2007-04-11 2013-10-30 キッセイ薬品工業株式会社 含窒素複素環化合物およびそれを含有する医薬組成物
CA2682391C (en) * 2007-04-11 2014-07-08 Kissei Pharmaceutical Co., Ltd. (aza)indole derivative and use thereof for medical purposes
PL2415771T3 (pl) * 2009-03-31 2014-01-31 Kissei Pharmaceutical Pochodna indolizyny i jej zastosowanie do celów medycznych

Also Published As

Publication number Publication date
CN104592224B (zh) 2016-08-03
US9643969B2 (en) 2017-05-09
JP5906191B2 (ja) 2016-04-20
US20130217878A1 (en) 2013-08-22
KR20130099064A (ko) 2013-09-05
ES2549926T3 (es) 2015-11-03
EP2623505B1 (en) 2015-07-29
CA2811773A1 (en) 2012-04-05
HK1206360A1 (zh) 2016-01-08
CN103221412A (zh) 2013-07-24
JPWO2012043638A1 (ja) 2014-02-24
CN104592224A (zh) 2015-05-06
EP2623505A4 (en) 2013-10-02
WO2012043638A1 (ja) 2012-04-05
EP2623505A1 (en) 2013-08-07
CN103221412B (zh) 2015-08-19

Similar Documents

Publication Publication Date Title
HK1206360A1 (zh) 氮雜 中氮茚衍生物及其藥物用途
HK1165793A1 (zh) 中氮茚衍生物及其醫藥用途
EP2600876A4 (en) METHODS AND APPARATUSES FOR COMBINED DRUG DELIVERY
GB201010193D0 (en) Medicinal use
ZA201300100B (en) Indolizine derivatives,process for the preparation thereof and therapeutic use thereof
EP2634176A4 (en) PYRIDINE DERIVATIVE AND MEDICINAL AGENT
EP2583651A4 (en) ROLLING CHAIR AND BED
HK1169960A1 (en) Pharmaceutical formulation
AP3441A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
GB2486567B (en) Pharmaceutical formulation
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
IL228433A0 (en) Pyridopyrazine history and their use
PT2521445T (pt) Formulação e utilização da mesma
IL226003A0 (en) Derivation of trans-2-decenoic acid and a pharmaceutical agent containing it
IL223254A0 (en) Use of diatomaceous earth in the pharmaceutical industry
EP2560614A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR ADMINISTRATION
IL221087A (en) Pharmacy or nutritional composition
IL223707A0 (en) N-hydroxyformamide derivative and medicament containing same
IL226388A0 (en) New indolizine derivatives, their preparation and medical use
GB201002451D0 (en) Pharmaceutical comopitions and devices
GB201012660D0 (en) Inhaler and formulation
GB201112578D0 (en) Pharmaceutical preparation and use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191002